Effect of Dexmedetomidine on Pacemaker Function Following Cardiac Surgery
- Registration Number
- NCT02709200
- Lead Sponsor
- Nationwide Children's Hospital
- Brief Summary
This is a prospective study looking at the effects of dexmedetomidine on pacemaker function in patients who have surgery for congenital heart disease utilizing cardiopulmonary bypass (CBP). For the purpose of the study, no change in intraoperative care will be dictated. The use of dexmedetomidine will be left up to the discretion of the treating physicians. The study will involve only the collection of data regarding the amplitude required to capture and specific demographics and intraoperative features including cross clamp time, time on CPB, and vasoactive agents that were and are being administered. In addition to these data, it will be noted whether dexmedetomdine was used or not and whether it is being administered on arrival to the CTICU.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- Patients with temporary surface pacemaker leads following surgery for congenital heart disease.
- Patients with single ventricle anatomy
- Patients receiving epinephrine
- Infants less than 6 months of age
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Dexmedetomidine Dexmedetomidine Patients that received dexmedetomidine during open heart surgery.
- Primary Outcome Measures
Name Time Method Amplitude Baseline The impulse required to elicit atrial or ventricle capture (contraction) of the surface electrode of a temporary postoperative pacemaker.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Nationwide Children's Hospital
🇺🇸Columbus, Ohio, United States